The new health and wellness tests developed by GC LabTech will be sold in the direct-to-consumer sector, which already has a $1 billion market, according to a report from Transparency Marketing.
1health.io will use its direct-to-consumer platform to enable GC LabTech to sell its tests. The platform has an e-commerce storefront and features to manage patient information, including kit registration, sample tracking and reporting, according to an Oct. 24 news release.
GC LabTech had previously attempted to enter the at-home testing market but did not have the correct infrastructure to make the tests available to consumers.
“1health was the missing link we needed to sell our lab testing products directly to consumers,” GC LabTech COO Brian Clark said in the press release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.